UNIVERSITAT ZURICH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 100156
 
  
 
C07K PEPTIDES 6573
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 36131
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 31175
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 15125
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 14226
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1386
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 11114
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1085
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 990

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0072,774 BACKBONE-CYCLIZED PEPTIDOMIMETICS WITH GLP-1R MODULATING ACTIVITYApr 06, 16Mar 15, 18[A61K, C40B, C07K]
2018/0066,070 ACETYLATED PCSK9Feb 17, 16Mar 08, 18[A61K, C07K]
2018/0015,144 AGONISTS OF THE NOGO-A S1PR PATHWAY FOR THE TREATMENT OF GLIOBLASTOMAJan 27, 16Jan 18, 18[A61K]
2018/0018,558 METHOD FOR NEURAL NETWORK AND APPARATUS PERFORMING SAME METHODMay 26, 17Jan 18, 18[G06N, G06F]
2018/0009,907 NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASESSep 15, 17Jan 11, 18[A61K, C12Q, G01N, C07K]
2018/0002,409 Human Anti-Tau AntibodiesFeb 08, 17Jan 04, 18[A61K, G01N, C07K]
2018/0003,711 DIRECTED EVOLUTION OF MEMBRANE PROTEINS IN EUKARYOTIC CELLS WITH A CELL WALLDec 21, 15Jan 04, 18[C12N, G01N]
2017/0369,592 NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) ANTIBODIES AND USES DERIVED THEREOFJan 11, 16Dec 28, 17[A61K, C12N, G01N, C07K]
2017/0370,942 HIGHLY MULTIPLEXED ABSOLUTE QUANTIFICATION OF MOLECULES ON THE SINGLE CELL LEVELAug 14, 15Dec 28, 17[G01N]
2017/0300,813 INTERFACE NEURAL NETWORKAug 25, 16Oct 19, 17[G06N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9915713 Determining positions of a magnetic field probe in a magnetic resonance measurementApr 20, 12Mar 13, 18[G01R]
9896504 Human anti-alpha-synuclein antibodiesJan 25, 16Feb 20, 18[C07K]
9879047 Template-fixed peptidomimeticsDec 15, 16Jan 30, 18[A61K, C07K]
9857381 Method for assaying sepsis in humansMar 29, 13Jan 02, 18[G01N]
9828420 Method of providing disease-specific binding molecules and targetsMar 10, 16Nov 28, 17[A61K, G01N, C07K]
9828638 Mutations in SPTLC2 gene associated with sensory neuropathySep 19, 11Nov 28, 17[C12Q]
9791526 Dynamic field camera arrangement for magnetic resonance applications and methods for operating the sameApr 23, 12Oct 17, 17[G01R, G01V]
9771413 Recombinant human antibodies for therapy and prevention of polyomavirus-related diseasesJan 02, 14Sep 26, 17[A61K, C12N, G01N, C07K]
9744336 Device for gravity-driven control of the filling pressure of a catheter balloonMar 22, 13Aug 29, 17[A61M]
9746419 Optical MRI deviceMay 05, 10Aug 29, 17[G01N, A61B]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0174,632 4-OXO-1, 4-DIHYDROQUINOLINE-3-CARBOXAMIDE AS SELECTIVE LIGAND FOR CANNABINOID RECEPTOR 2 FOR DIAGNOSIS AND THERAPYAbandonedJul 08, 15Jun 22, 17[A61K, C07D]
2016/0207,950 ORGANOMETALLIC N-2-CYANO-1-HYDROXYPROPAN-2-YL FOR USE AS ANTHELMINTICSAbandonedSep 26, 14Jul 21, 16[C07F]
2015/0329,646 NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASESAbandonedMay 11, 15Nov 19, 15[A61K, C07K]
2015/0232,542 HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIESAbandonedJan 08, 15Aug 20, 15[A61K, G01N, C07K]
2015/0203,828 N-GLYCAN CORE BETA-GALACTOSYLTRANSFERASE AND USES THEREOFAbandonedFeb 21, 14Jul 23, 15[C12N]
2015/0147,343 METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETSAbandonedJul 02, 14May 28, 15[G01N, C07K]
2014/0343,324 SYNTHETIC MATRIX FOR CONTROLLED CELL INGROWTH AND TISSUE REGENERATIONAbandonedMay 21, 14Nov 20, 14[C07C]
2014/0213,531 TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH PROTEASE INHIBITORY ACTIVITIYAbandonedDec 09, 13Jul 31, 14[C07K]
2014/0186,363 MAGEA3 BINDING ANTIBODIESAbandonedMay 23, 12Jul 03, 14[C07K]
2014/0141,410 FELINE LEUKEMIA VIRUS TRANS-MEMBRANE PROTEIN P15E FOR DIAGNOSIS OF FELV INFECTIONAbandonedJul 06, 12May 22, 14[G01N, C07K]
2014/0141,522 OPTICAL DETECTION OF CYANIDES, METHOD, KIT AND DEVICEAbandonedApr 05, 12May 22, 14[G01N]
2014/0106,297 DENTAL BUR AND METHOD FOR REMOVING A SOFT DEPOSITAbandonedMar 15, 13Apr 17, 14[A61C]
2014/0093,514 MAGEA3 BINDING ANTIBODIESAbandonedMay 23, 12Apr 03, 14[C07K]
2014/0094,588 PROGNOSTIC AND THERAPEUTIC SIGNATURE FOR MALIGNANT MELANOMAAbandonedMar 30, 12Apr 03, 14[G01N]
2014/0074,099 SURGICAL GUIDES AND METHODS FOR MANUFACTURING THEREOFAbandonedNov 14, 13Mar 13, 14[A61B]
2014/0050,735 TREATMENT OF FISTULIZING CHROHN'S DISEASEAbandonedFeb 15, 12Feb 20, 14[A61K, C07K]
2014/0044,644 ANKYRIN G AND MODULATORS THEREOF FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERSAbandonedFeb 21, 12Feb 13, 14[A61K, G01N]
2013/0326,315 EVALUATION OF POLYNOMIALS OVER FINITE FIELDS AND DECODING OF CYCLIC CODESAbandonedJan 18, 12Dec 05, 13[H03M]
2013/0302,343 MODULATORS OF IL-12 AND/OR IL-23 FOR THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASEAbandonedJan 04, 12Nov 14, 13[A61K, G01N]
2013/0295,021 HUMAN ANTI-TAU ANTIBODIESAbandonedOct 11, 11Nov 07, 13[A61K, G01N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.